Correlation Between Crinetics Pharmaceuticals and AnaptysBio

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Crinetics Pharmaceuticals and AnaptysBio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Crinetics Pharmaceuticals and AnaptysBio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Crinetics Pharmaceuticals and AnaptysBio, you can compare the effects of market volatilities on Crinetics Pharmaceuticals and AnaptysBio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Crinetics Pharmaceuticals with a short position of AnaptysBio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Crinetics Pharmaceuticals and AnaptysBio.

Diversification Opportunities for Crinetics Pharmaceuticals and AnaptysBio

-0.53
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Crinetics and AnaptysBio is -0.53. Overlapping area represents the amount of risk that can be diversified away by holding Crinetics Pharmaceuticals and AnaptysBio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AnaptysBio and Crinetics Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Crinetics Pharmaceuticals are associated (or correlated) with AnaptysBio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AnaptysBio has no effect on the direction of Crinetics Pharmaceuticals i.e., Crinetics Pharmaceuticals and AnaptysBio go up and down completely randomly.

Pair Corralation between Crinetics Pharmaceuticals and AnaptysBio

Given the investment horizon of 90 days Crinetics Pharmaceuticals is expected to generate 0.31 times more return on investment than AnaptysBio. However, Crinetics Pharmaceuticals is 3.21 times less risky than AnaptysBio. It trades about -0.03 of its potential returns per unit of risk. AnaptysBio is currently generating about -0.29 per unit of risk. If you would invest  5,840  in Crinetics Pharmaceuticals on August 24, 2024 and sell it today you would lose (137.00) from holding Crinetics Pharmaceuticals or give up 2.35% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy95.65%
ValuesDaily Returns

Crinetics Pharmaceuticals  vs.  AnaptysBio

 Performance 
       Timeline  
Crinetics Pharmaceuticals 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Crinetics Pharmaceuticals are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Crinetics Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in December 2024.
AnaptysBio 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days AnaptysBio has generated negative risk-adjusted returns adding no value to investors with long positions. Despite inconsistent performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Crinetics Pharmaceuticals and AnaptysBio Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Crinetics Pharmaceuticals and AnaptysBio

The main advantage of trading using opposite Crinetics Pharmaceuticals and AnaptysBio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Crinetics Pharmaceuticals position performs unexpectedly, AnaptysBio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AnaptysBio will offset losses from the drop in AnaptysBio's long position.
The idea behind Crinetics Pharmaceuticals and AnaptysBio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Other Complementary Tools

Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Stocks Directory
Find actively traded stocks across global markets
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments